Jesse Hall

819 total citations
23 papers, 498 citations indexed

About

Jesse Hall is a scholar working on Nephrology, Surgery and Oncology. According to data from OpenAlex, Jesse Hall has authored 23 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 11 papers in Surgery and 5 papers in Oncology. Recurrent topics in Jesse Hall's work include Gout, Hyperuricemia, Uric Acid (13 papers), Case Reports on Hematomas (8 papers) and Bone health and treatments (3 papers). Jesse Hall is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (13 papers), Case Reports on Hematomas (8 papers) and Bone health and treatments (3 papers). Jesse Hall collaborates with scholars based in United States, United Kingdom and Poland. Jesse Hall's co-authors include Patrick Murray, Zancong Shen, Michael Gillen, Sha Liu, Jeffrey N. Miner, Rachel B. Wagman, Xiaohong Yan, Sydney Lou Bonnick, Henry G. Bone and Michael A. Bolognese and has published in prestigious journals such as Blood, Gastroenterology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jesse Hall

23 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesse Hall United States 12 259 153 150 148 124 23 498
K.-H. Shu Taiwan 12 144 0.6× 149 1.0× 50 0.3× 13 0.1× 85 0.7× 38 493
Ranjan Mascarenhas United States 8 65 0.3× 241 1.6× 268 1.8× 11 0.1× 103 0.8× 14 636
Takayoshi Yokoyama Japan 10 44 0.2× 279 1.8× 99 0.7× 15 0.1× 69 0.6× 47 535
Özlem Harmankaya Türkiye 12 176 0.7× 77 0.5× 75 0.5× 3 0.0× 68 0.5× 41 454
Mario Plebani Italy 8 108 0.4× 91 0.6× 12 0.1× 12 0.1× 44 0.4× 11 357
Gabriel Diem Austria 9 78 0.3× 50 0.3× 94 0.6× 5 0.0× 74 0.6× 20 349
Hyun Hee Lee South Korea 8 105 0.4× 69 0.5× 30 0.2× 4 0.0× 43 0.3× 29 287
Bhawana Ashok Badhe India 12 13 0.1× 109 0.7× 67 0.4× 8 0.1× 68 0.5× 68 420
Jytte L. Birnbaum United States 9 67 0.3× 118 0.8× 41 0.3× 4 0.0× 50 0.4× 13 449
Tatsuo Yoneda Japan 12 57 0.2× 106 0.7× 24 0.2× 5 0.0× 60 0.5× 75 430

Countries citing papers authored by Jesse Hall

Since Specialization
Citations

This map shows the geographic impact of Jesse Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse Hall more than expected).

Fields of papers citing papers by Jesse Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse Hall. The network helps show where Jesse Hall may publish in the future.

Co-authorship network of co-authors of Jesse Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse Hall. A scholar is included among the top collaborators of Jesse Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse Hall. Jesse Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansson, Susanne, David Han, Thomas R. Hunt, et al.. (2022). Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non‐Asian participants. Pharmacology Research & Perspectives. 10(3). e00929–e00929. 5 indexed citations
2.
Abedin, Sameem, Mehdi Hamadani, Shernan G. Holtan, et al.. (2022). Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host-Disease (SR-aGVHD) or Treatment-Refractory Acute Graft-Versus-Host-Disease (TR-aGVHD). Blood. 140(Supplement 1). 10495–10497. 7 indexed citations
3.
Colombel, Jean‐Frédéric, et al.. (2019). P053 TARGETED RELEASE ORAL CYCLOSPORINE FORMULATION AS A POTENTIAL NEW THERAPY FOR ULCERATIVE COLITIS. Gastroenterology. 156(3). S37–S38. 3 indexed citations
4.
Hall, Jesse, Michael Gillen, Sha Liu, et al.. (2018). Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects. Drug Design Development and Therapy. Volume 12. 1799–1807. 10 indexed citations
5.
Fleischmann, R., Peter Winkle, Jeffrey N. Miner, et al.. (2018). Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study. RMD Open. 4(1). e000584–e000584. 37 indexed citations
6.
Fleischmann, Roy, Peter Winkle, Jesse Hall, et al.. (2018). Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study. RMD Open. 4(1). e000647–e000647. 11 indexed citations
7.
Yang, Chun, Zancong Shen, David M. Wilson, et al.. (2018). Metabolism and Disposition of Verinurad, a Uric Acid Reabsorption Inhibitor, in Humans. Drug Metabolism and Disposition. 46(5). 532–541. 13 indexed citations
8.
Smith, William B., Jesse Hall, Jolene Kay Berg, et al.. (2018). Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor. Clinical Drug Investigation. 38(8). 703–713. 8 indexed citations
9.
Shiramoto, Masanari, Sha Liu, Zancong Shen, et al.. (2018). Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study. Lara D. Veeken. 57(9). 1602–1610. 30 indexed citations
10.
Yang, Chun, Zancong Shen, Bradley M. Kerr, et al.. (2018). Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans. Xenobiotica. 49(7). 811–822. 10 indexed citations
11.
Kankam, Martin, Jesse Hall, Michael Gillen, et al.. (2018). Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout. The Journal of Clinical Pharmacology. 58(9). 1214–1222. 16 indexed citations
12.
Shen, Zancong, et al.. (2017). Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects. Drug Design Development and Therapy. Volume 11. 2077–2086. 35 indexed citations
13.
Manthripragada, Angelika D., C. D. O’Malley, Uģis Gruntmanis, et al.. (2015). Fracture incidence in a large cohort of men age 30 years and older with osteoporosis. Osteoporosis International. 26(5). 1619–1627. 10 indexed citations
14.
15.
Recknor, Chris, E. J. Czerwiński, Henry G. Bone, et al.. (2013). Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy. Obstetrics and Gynecology. 121(6). 1291–1299. 110 indexed citations
16.
Orwoll, Eric, Bente Langdahl, R. Chapurlat, et al.. (2011). A phase 3 study of the efficacy and safety of Denosumab in men with low bone mineral density : design of the ADAMO. Open Repository and Bibliography (University of Liège). 1 indexed citations
17.
Fülöp, Tibor, Jake Olivier, Jesse Hall, et al.. (2010). Screening for chronic kidney disease in the ambulatory HIV population. Clinical Nephrology. 73(3). 190–196. 13 indexed citations
18.
Quaye, Stephen John, et al.. (2008). Student Voice and Sensemaking of Multiculturalism on Campus. 2 indexed citations
19.
Jones, T. Hugh, et al.. (2004). Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men. European Journal of Endocrinology. 150(1). 57–63. 18 indexed citations
20.
Murray, Patrick & Jesse Hall. (2000). Renal Replacement Therapy for Acute Renal Failure. American Journal of Respiratory and Critical Care Medicine. 162(3). 777–781. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.-H. Shu Breakdown of academic impact, for papers by Ranjan Mascarenhas Breakdown of academic impact, for papers by Takayoshi Yokoyama Breakdown of academic impact, for papers by Özlem Harmankaya Breakdown of academic impact, for papers by Mario Plebani Breakdown of academic impact, for papers by Gabriel Diem Breakdown of academic impact, for papers by Hyun Hee Lee Breakdown of academic impact, for papers by Bhawana Ashok Badhe Breakdown of academic impact, for papers by Jytte L. Birnbaum Breakdown of academic impact, for papers by Tatsuo Yoneda
Rankless by CCL
2026